A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : FACIT-F / Functional Assessment of Chronic Illness Therapy-Fatigue

[Related PubMed/MEDLINE]
Total Number of Papers: 172
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   FACIT-F  (>> Co-occurring Abbreviation)
Long Form:   Functional Assessment of Chronic Illness Therapy-Fatigue
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Content Validity of Sjögren's Syndrome Symptom Diary and Functional Assessment of Chronic Illness Therapy-Fatigue in Patients with Sjögren's. PRO, SSSD
2022 Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials. ADVANCE, EQ-5D-5L, HRQoL, IBDQ, s.c
2022 Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies. DSS, HAQ-DI, MCS, PASDAS, PCS, PF, PROs, PsA, SF-36, WLQ
2022 Efficacy and safety of Janus kinase inhibitors in patients with ankylosing spondylitis: A systematic review and meta-analysis. AEs, AS, ASAS, BASDAI, BASFI, BASMI, JAK, MASES, RCTs, SAEs, SF-36 PCS, WPAI
2022 Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, Middle East, and Turkey: final analysis of CITE. cITP
2022 Fatigue and Sleep Disturbance among Breast Cancer Patients during Treatment in Saudi Arabia. PSQI
2022 Fatigue is a systemic extraintestinal disease manifestation largely independent of disease activity, chronicity, and nutritional deficiencies in inflammatory bowel disease on biologics. IBD, PCA
2022 Functional Assessment of Chronic Illness Therapy-Fatigue is a reliable and valid measure in patients with active ankylosing spondylitis. AS, PtGA
2022 Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN). LN, LupusQoL, NRS, PROs, SLE
10  2022 Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren's Syndrome. MS, SNPs, SS
11  2022 Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled Trial. CRF, ESAS, OLP, WL
12  2022 Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial. ABA, bDMARD-IR, csDMARDs, EQ-5D-5L, HAQ-DI, LSM, MCID, PCS, PROs, PtGA, RA, UPA, VAS, WPAI
13  2022 Prevalence of self-reported fatigue in intensive care unit survivors 6 months-5 years after discharge. ICU
14  2022 Routine cancer treatments and their impact on physical function, symptoms of cancer-related fatigue, anxiety, and depression. HADS, HGS, PhA
15  2022 Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo. HAQ-DI, MDA, PASDAS
16  2022 Time-restricted Eating to Address Cancer-related Fatigue among Cancer Survivors: A Single-arm Pilot Study. BFI, ES, TRE
17  2022 Validation of two new scales for the assessment of fatigue in Multiple Sclerosis: F-2-MS and FACIT-F. FSS, MFIS
18  2022 Yunpi Qufeng Chushi Formula for Pre-Rheumatoid Arthritis: Study Protocol for a Multiple-Center, Double-Blind, Placebo-Controlled Randomized Controlled Trial. CDAI, HAQ-DI, RA, SDAI, TCM, YQCF
19  2021 Anamorelin combined with physical activity, and nutritional counseling for cancer-related fatigue: a preliminary study. CRF, MFSI-SF
20  2021 Assessment of Functional Status and Quality of Life of Elderly Patients Undergoing Radiotherapy and Radiotherapy Combined with Chemotherapy - A Cross-Sectional Study. ECOG, FWB, GDS, IADL
21  2021 Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B. CHB, CHD, CLDQ, HRQoL, PROs, WPAI
22  2021 Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trial. EPIC, FACT-G, FACT-P, QoL
23  2021 Fatigue in psoriatic arthritis: Is it related to disease activity? DAPSA, PASI, PsA
24  2021 Harnessing digital health to objectively assess cancer-related fatigue: The impact of fatigue on mobility performance. BMI, CIPN, CRF, FACT-G, FES-I, MtV
25  2021 Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis. BMI, HAQ-DI, PASI, PCS, PsA, SF-36v2
26  2021 Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1. HAQ-DI, MCID, non-bDMARD-IR, PROs, PsA, PtGA, SF-36
27  2021 Multiple myeloma and physical activity. FACT-G, GLTEQ
28  2021 Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study. HAQ-DI, MTX, PROs, RA
29  2021 Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis. CDAI, DAS28-ESR, ESR, HAQ-DI, MCID, PRO, RA, RCI, SJC, TJC, WPAI
30  2021 Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib. MDA, Pain VAS, PASDAS, PROs, PsA
31  2021 S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens. SAM
32  2021 Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE. HAQ-DI, LSM, MCIDs, PCS, PROs, PtGA, VAS
33  2021 [Clinical Study on Calcitriol Combined with Sirolimus in the Treatment of Chronic Primary Immune Thrombocytopenia Patients]. cITP, PLT, VDR, WHO
34  2020 A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures. NCORP, URMC
35  2020 Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib. csDMARD-IR, csDMARDs, HAQ-DI, PROs, PtGA, RA
36  2020 Benefit of Biological Drugs for Quality of Life in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Clinical Trials. AS, ASAS, ASQoL, BASDAI, BASFI, QoL
37  2020 Biologic disease-modifying anti-rheumatic drugs and patient-reported outcomes in axial SpA: a systematic review and a call for action. ASQoL, axSpA, BASDAI, BASFI, bDMARDs, EQ-5D, IL17Ai, MCID, nr-axSpA, PBO, PROs, r-axSpA, RCT, SF36-MCS, SF36-PCS, SLR, TNFi
38  2020 Bristol rheumatoid arthritis fatigue scale is valid in patients with psoriatic arthritis and is associated with overall severe disease and higher comorbidities. CCI, PsA
39  2020 Conversion of Functional Assessment of Chronic Illness Therapy-Fatigue to Patient-Reported Outcomes Measurement Information System Fatigue Scores in Two Phase III Baricitinib Rheumatoid Arthritis Trials. PROMIS, RA
40  2020 Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial. CRF, ERYT
41  2020 Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients. csDMARDs, DAS28-ESR, HRQoL, RA
42  2020 Health-Related Quality of Life and Burden of Fatigue in Chinese Patients with Immune Thrombocytopenia: A Cross-Sectional Study. CI, HRQoL, ITP
43  2020 Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free. ANOVA, CLDQ, DAA, HRQoL, IFN, PROs, PROs, PROs, RBV, SF-36, SVR
44  2020 Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus Derived from a Digital Therapeutic Plus Tele-Health Coaching Intervention: Randomized Controlled Pilot Trial. BPI-SF, HRQoL, LupusQoL, SLE
45  2020 Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience. AIH, AILD, CLD, CLDQ, HRQL, NAFLD, PBC, PROs, WPAI
46  2020 Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus. BILD, HRQoL, LIT, SF-36, SLAQ, SLE
47  2020 Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren's Syndrome: A Randomized Clinical Trial. DSST, ESSPRI, EULAR, ProF, SS
48  2020 Interventions for fatigue in inflammatory bowel disease. AEs, CBT, IBD, IBD-F, MD
49  2020 Measuring fatigue: a meta-review. ---
50  2020 Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE. ACR20, hs-CRP, RA
51  2020 Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long-Term Results of Two Phase III Randomized Controlled Trials. AS, ASAS
52  2020 Sleep quality is associated with Disability and Quality of life in breast cancer survivors: a cross-sectional pilot study. DASH, PSQI, WHODAS 2.0
53  2020 The impact of fatigue on patients with psoriatic arthritis: amulti-center study of the TLAR-network. BASDAI, cDAPSA, DAPSA, DAS28, FiRST, MDA, PsA, TLAR, VLDA
54  2020 THE INFLAMMATORY BOWEL DISEASE-FATIGUE PATIENT SELF-ASSESSMENT SCALE: TRANSLATION, CROSS-CULTURAL ADAPTATION AND PSYCHOMETRIC PROPERTIES OF THE BRAZILIAN VERSION (IBD-F BRAZIL). IBD, IBD-F
55  2020 The short-term effects of balneotherapy on pain, disability and fatigue in patients with chronic low back pain treated with physical therapy: A randomized controlled trial. BMI, BT, EQ5, PT, QBPDS, RMDQ, VAS
56  2019 Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C. BDI-II, CHC, CLDQ-HCV, FSS, PROs, SF-36, SVR
57  2019 Depression, disability and sleep disturbance are the main explanatory factors of fatigue in rheumatoid arthritis: a path analysis model. RA
58  2019 Disease activity and sleep quality in rheumatoid arthritis: a deeper look into the relationship. DAS28, HRQoL, PSQI, RA
59  2019 Effect of balneotherapy on pain and fatigue in elderly with knee osteoarthritis receiving physical therapy: a randomized trial. BT, EPWORTH, KOA, PT, WOMAC
60  2019 Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study. BASDAI, BASFI, BASRI-s, CASPAR, DAS 28-ESR, HADS, HAQ, HAQ-s, MASES, PASI, PsA, PsAQoL, SF-36, TLAR
61  2019 Evaluation of fatigue in inflammatory bowel disease - a useful tool in daily practice. CD, IBD
62  2019 Fatigue and Functional Ability in Patients Undergoing Upfront Surgical Treatment for Solid Malignancies. MFI-20
63  2019 Psychometric Properties of the Arabic Version of the Functional Assessment of Chronic Illnesses Therapy-Fatigue in Arabic Cancer Patients. FACIT, FACT-G
64  2019 Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial. RA
65  2019 The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis. EQ5D3L, HADS, HRQoL, MES, PROs, SIBDQ, UC, WPAI
66  2019 The efficacy of placebo for the treatment of cancer-related fatigue: a systematic review and meta-analysis. BFI, CRF
67  2019 Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib. AEs, CFB, csDMARD, HAQ-DI, LDA, RA, RF, SF-36
68  2019 Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder. CI, NMOSD, VAS
69  2019 Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT. HAQ-DI, LSM, MCIDs, NNT, PROs, PtGA, SF-36
70  2018 Anxiety and Extraversion in Lupus-Related Atherosclerosis. CVD, IMT, SLE, STAI
71  2018 Effects of Exergaming in Cancer Related Fatigue in the Quality of Life and Electromyography of the Middle Deltoid of People with Cancer in Treatment: A Controlled Trial ---
72  2018 Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO. aHUS, ECU, EMPRO, HIT-6, HRQoL, HUS, PROs, QoL, VAS
73  2018 Fatigue predicts impaired social adjustment in survivors of allogeneic hematopoietic cell transplantation (HCT). DE, ER, HCT, PAIS, SE, SEX, VE
74  2018 Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial. CRP, EE, HAQ-DI, MCIDs, PROs, PsA, SF-36, TNFi
75  2018 Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. CLL/SLL
76  2018 Investigating the relationships between quality of life, fatigue and leisure time physical activity in prostate cancer patients. FACT-P, GLTEQ, PCa
77  2018 Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis. HAQ-DI, LSM, MCID, MCS, PCS, PROs, PtGA, RA, RAID, VASs
78  2018 Potential Role of Bupropion Sustained Release for Cancer-Related Fatigue: a Double-Blind, Placebo-Controlled Study ANCOVA, CRF, SR
79  2018 Prevalence and Correlation of Depressive Symptoms with Functional Scores, Therapy and Disease Activity among Croatian Patients with Rheumatoid Arthritis: A Preliminary Study. BDI-II, DAS28, HAQ, HRQL, RA, VAS
80  2018 Shenmai injection for the treatment of cancer-related fatigue in advanced non-small cell lung cancer patients undergoing chemotherapy: study protocol for a randomized controlled trial. CRF, NSCLC, RCT, SMI, TCM
81  2018 Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial. csDMARDs, HAQ-DI, PGA, PtGA, RA, SF-36, WLQ
82  2018 Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C. CLDQ, DCV, HCV, PROs, RBV, SF-36, SMV, SOF
83  2017 A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population. FACT-Br, HRQoL, NCCN-DT
84  2017 A Double-Blind, Randomized, Placebo-Controlled Trial of Panax Ginseng for Cancer-Related Fatigue in Patients With Advanced Cancer. CRF, ESAS, PG, QoL
85  2017 Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis. BASDAI, CDAI, FACIT-FS, HAD, HAD A, HAD D, HAQ, PASI, PDI
86  2017 Fatigue and sleep quality in rheumatoid arthritis patients during hospital admission. PSQI, RA
87  2017 Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia. EQ-5D-5L, FAACT, HRQoL, MAE, RMSE, TOI
88  2017 Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. EQ-5D, HAQ-DI, MJS, MTX, PROs, PtGA, WPAI-RA
89  2017 Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. HAQ-DI, MJS, PROs, PtGA, RA, VAS
90  2017 Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. ANCOVA, DMARDs, EQ-5D, HAQ-DI, MJS, MTX, PROs, PtGA, RA, SF-36, WPAI-RA
91  2017 Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. CLDQ-HCV, HCV, PROs, WPAI
92  2017 Predictors of health-related quality of life in Korean prostate cancer patients receiving androgen deprivation therapy. ADT, FACT-P, HADS, HRQoL
93  2017 Psychometric properties of the Chinese version of Arthritis Self-Efficacy Scale-8 (ASES-8) in a rheumatoid arthritis population. ASES-8, HADS, ICC, SF-36
94  2017 Subjective measures of work-related fatigue in automobile factory employees. MFI, PSQI, WCQ
95  2017 The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus. ESR, HRQoL, SLE, SLEDAI, SLEQOL-C
96  2016 A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy. BFI, CFS, FACT-G, QoL, RT
97  2016 Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens. CLDQ-HCV, HCV, PROs, RBV, SF-36, SOF, WPAI
98  2016 Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies. LTE
99  2016 Art therapy using famous painting appreciation maintains fatigue levels during radiotherapy in cancer patients. BFI, QoL
100  2016 Biologic interventions for fatigue in rheumatoid arthritis. anti-TNF, CENTRAL, CI, DMARDs, NRS, RA, SF-36 VT, VAS